FDA EIR - Centerchem - June 30, 2009

An FDA surveillance inspection of CenterChem, Inc., located in Norwalk, CT, was conducted on July 8, 2009. The inspection's purpose was to assess domestic food safety, aligning with regulatory framework CP7303.803, and covered the company's role as a corporate headquarters for multiple industry codes including food warehouses, human and animal drugs, physical medicine, and biotechnology/medical device/food/feed/pharmaceutical warehouse operations. CenterChem functions solely as a corporate office, managing various storage facilities throughout the U.S. and specializing in wholesale ingredients for food additives, cosmetic ingredients, pharmaceuticals, and biochemical products. The inspection revealed no objectionable conditions or main violations. Consequently, no FDA Form 483, which would list observed deficiencies, was issued. The FDA concluded the inspection with a "No Action Indicated" classification, signifying that no further regulatory actions were required from the company. The only action noted was an internal update to FDA records to reflect the firm's status as a corporate office only.